LARRY KISBY: Open Payments
NPI 1639127517 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 24 payments from 14 companies in 2025. Trend: 2023 $758 · 2024 $424 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $104 |
| Viatris Specialty LLC | 2 | $47 |
| Pelvital USA, Inc. | 1 | $42 |
| Amgen Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $30 |
| PFIZER INC. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: Ozempic, YUPELRI, EVENITY, Wegovy, AIRSUPRA, TZIELD, JARDIANCE, XIFAXAN.
Industry payments across NE — which companies pay providers there.
